Phenotypes and Cellular Mechanics of Primary Human Aorta- and Pluripotent Stem Cell-derived Vascular Smooth Muscle Cells

Inside the walls of our blood vessels lies a specialized layer of muscle cells that acts as the body's master regulator of blood flow. These cells, known as vascular smooth muscle cells, are the gatekeepers of circulation. When they are healthy and mature, they remain calm and tightly contracted, holding the vessel open with a steady, powerful grip to maintain blood pressure. However, when the body needs to repair damage or when disease strikes, these same cells can change their nature. They can relax their grip, grow larger, and multiply rapidly to patch up a tear or build new tissue. This ability to switch between a steady, contractile state and a busy, growing state is vital for health, but it is also the engine behind many dangerous conditions, such as the weakening and ballooning of arteries known as aneurysms. To understand how these cells work and why they sometimes fail, scientists need to study them in the lab. For decades, researchers have relied on taking these cells directly from human donors, but this approach has a significant flaw: every donor is different, and the cells often change their behavior once removed from the body, making it hard to tell if a result is due to a specific disease or just natural variation between people.

To solve this problem, a team of researchers turned to a more consistent source: human pluripotent stem cells. These are master cells capable of becoming any type of tissue in the body. By guiding these stem cells down a specific developmental path, the scientists created a fresh supply of vascular smooth muscle cells in a dish. The goal of their new study was to see if these lab-grown cells truly behaved like the real thing found in human arteries. They compared their stem-cell-derived cells against cells harvested directly from human aortas, the large vessels that carry blood from the heart. The researchers wanted to know if the lab-made cells could mimic the two main states of the real cells: the busy, growing state and the calm, contractile state. They also wanted to measure the physical strength of these cells, checking how much force they could exert on their surroundings, a key factor in how blood vessels hold their shape.

The team began by growing their stem-cell-derived cells and carefully guiding them to become the smooth muscle type. They found that these cells could indeed switch between the two states. When left alone, they acted like the growing, synthetic version of the cell, multiplying and filling the space. When the researchers added a specific chemical inhibitor to the culture, the cells stopped dividing and transformed into the mature, contractile type. These treated cells grew larger, developed stronger internal fibers, and produced higher levels of the proteins responsible for muscle contraction. To ensure these lab-grown cells were not just looking the part but acting the part, the team measured their physical strength. They placed single cells on tiny, flexible pillars and watched how much the pillars bent as the cells pulled on them. They also built small, three-dimensional tissues containing hundreds of cells and measured the collective force these tiny bundles generated as they tightened.

The results showed a striking similarity between the lab-grown cells and the cells taken from human donors. Both types of cells generated forces in a comparable range, pulling with a strength measured in the billionths of a newton per pillar. This confirmed that the stem-cell-derived cells were mechanically capable of doing the same work as the natural cells. However, the study also highlighted a major difference in reliability. The cells taken directly from human aortas varied wildly from one batch to another. Some batches were full of the desired muscle cells, while others contained mostly other cell types, and their strength and behavior changed unpredictably depending on the donor's age and the specific part of the artery they came from. In contrast, the stem-cell-derived cells were remarkably consistent. Every batch behaved the same way, responded to the chemical switch in the same manner, and produced the same amount of force.

The researchers also tested whether they could make the natural donor cells behave more like the mature, contractile type using the same chemical treatment. They found that it worked, but the response was inconsistent across different batches of donor cells. Some batches responded strongly, becoming much stronger and more contractile, while others showed little change. This inconsistency made it difficult to draw clear conclusions when using donor cells alone. The study concluded that while cells from human donors are useful, they come with too much noise to be the perfect tool for studying the mechanics of blood vessels. The stem-cell-derived cells, on the other hand, offer a clean, reproducible model. They can be switched on and off between growing and contracting states with high precision, and they generate forces that match the real human cells. This provides scientists with a reliable, standardized tool to study how blood vessels work, how they break down in disease, and how new drugs might help fix them, without the confusion of natural human variation.